Cantex Pharmaceuticals
Shawn Lu, a member of the board of directors, is the Chief Financial Officer and a director of Hepalink USA Inc. Mr. Lu has also been a director of Scientific Protein Laboratories LLC, and is a director of Resverlogix Corp. (TSE: RVX), of Quest Pharmatech (CVE: QPT). Mr. Lu holds a Master’s degree in Finance from Queen’s University in Canada, a Master’s degree in Corporate Economic and Business Administration from Zhongnan University of Economic & Law in China, and a B.S. degree in Engineering from Wuhan University of Transportation Technology in China.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cantex Pharmaceuticals
Cantex Pharmaceuticals, Inc. is a pharmaceutical company developing treatments of cancer, complications of COVID-19 infection, and pulmonary inflammatory diseases.